GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 117 filers reported holding GENERATION BIO CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160 | -71.6% | 42,319 | -67.7% | 0.01% | -75.0% |
| Q1 2023 | $564 | +66.4% | 131,146 | +52.2% | 0.06% | +33.3% |
| Q4 2022 | $339 | -99.9% | 86,154 | +3.9% | 0.04% | -27.6% |
| Q3 2022 | $440,000 | +263.6% | 82,946 | +349.4% | 0.06% | +222.2% |
| Q2 2022 | $121,000 | -4.0% | 18,457 | +4.0% | 0.02% | +12.5% |
| Q4 2021 | $126,000 | – | 17,739 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |